Skip to main content
Accelerating Clinical Trials in the EU
  • News article
  • 20 January 2025
  • European Medicines Agency
  • 1 min read

ACT EU workplan for 2025-2026 published

The ACT EU workplan for 2025-2026 is now available. 

The revised workplan highlights ACT EU’s areas of focus over the next two years, reflecting the feedback received through the multi-stakeholder platform advisory group and other channels: 

  • The operation of the Clinical Trials Regulation.
  • Maximising the impact of clinical trials.
  • Clinical trials in public health emergencies.

Clinical trial analytics, training, and communication remain integral to ACT EU’s work, and interlinked with all other activities. 

For more details, see: ACT EU workplan 2025-2026

Details

Publication date
20 January 2025
Author
European Medicines Agency